Treatment of type 2 diabetes mellitus

被引:35
作者
Feinglos, MN
Bethel, MA
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Endocrinol & Metab, Durham, NC 27710 USA
关键词
D O I
10.1016/S0025-7125(05)70023-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although most patients with type 2 diabetes mellitus can be initially managed with diet and exercise alone, most eventually require at least oral agents if not insulin to maintain glycemic control. Appropriate therapeutic regimens may be difficult to design, given the diversity of drugs available for clinical use. Physicians must consider not only glycemic control, but also patient preference, concomitant medical conditions, and cost when designing therapeutic regimens.
引用
收藏
页码:757 / +
页数:36
相关论文
共 122 条
[61]   Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitus [J].
Inoue, I ;
Takahashi, K ;
Noji, S ;
Awata, T ;
Negishi, K ;
Katayama, S .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1997, 36 (03) :143-151
[62]  
Iwamoto Y, 1996, DIABETIC MED, V13, P365, DOI 10.1002/(SICI)1096-9136(199604)13:4<365::AID-DIA19>3.0.CO
[63]  
2-M
[64]   Effects of troglitazone - A new hypoglycemic agents in patients with NIDDM poorly controlled by diet therapy [J].
Iwamoto, Y ;
Kosaka, K ;
Kuzuya, T ;
Akanuma, Y ;
Shigeta, Y ;
Kaneko, T .
DIABETES CARE, 1996, 19 (02) :151-156
[65]  
JABER LA, 1992, CLIN FOCUS, P29
[66]   Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes [J].
Jendle, JH ;
Karlberg, BE .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (06) :555-561
[67]   RANDOMIZED TRIAL COMPARING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION AND CONVENTIONAL INSULIN THERAPY IN TYPE-II DIABETIC-PATIENTS POORLY CONTROLLED WITH SULFONYLUREAS [J].
JENNINGS, AM ;
LEWIS, KS ;
MURDOCH, S ;
TALBOT, JF ;
BRADLEY, C ;
WARD, JD .
DIABETES CARE, 1991, 14 (08) :738-744
[68]   Oral antihyperglycaemics - Considerations in older patients with non-insulin-dependent diabetes mellitus [J].
Jennings, PE .
DRUGS & AGING, 1997, 10 (05) :323-331
[69]  
Kikuchi M, 1996, DIABETIC MED, V13, pS151
[70]  
Kumar S, 1996, DIABETOLOGIA, V39, P701